Company profile
Xenon Pharmaceuticals Inc. insider acquisitions
Company CIK 0001582313 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Exercise / conversionCode M | Common SharesNon-derivative · Currency not specified | 1 | Not applicable | 1 |
| PurchaseCode P | Common SharesNon-derivative · Currency not specified | 2 | 1,681,140 | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
6 dated transactions · 2 of 2 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 15, 2026 | Xenon Pharmaceuticals Inc.Common Shares | Kelly Thomas Patrick | Exercise / conversion |
| Sep 30, 2026 | Xenon Pharmaceuticals Inc.Common Shares | Kelly Thomas Patrick | Purchase |
| Sep 30, 2026 | Xenon Pharmaceuticals Inc.Common Shares | MORTIMER IAN | Purchase |
| Jan 2, 2026 | Xenon Pharmaceuticals Inc.Common Shares | MORTIMER IAN | Exercise / conversion |
| Oct 15, 2025 | Xenon Pharmaceuticals Inc.Restricted Share Units | Kelly Thomas Patrick | Stock award |
| Oct 15, 2025 | Xenon Pharmaceuticals Inc.Share Option (Right to Buy) | Kelly Thomas Patrick | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
XENE · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Kelly Thomas PatrickChief Financial Officer | Exercise / conversionCommon SharesNon-derivative security · Code M | 7,500 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Kelly Thomas PatrickChief Financial Officer | PurchaseCommon SharesNon-derivative security · Code P | 15,000 | 37.316Value: 559,740Currency not specified | View ↗ |
| Trade: | MORTIMER IANPRESIDENT & CEO · Director | PurchaseCommon SharesNon-derivative security · Code P | 30,000 | 37.38Value: 1,121,400Currency not specified | View ↗ |
| Trade: | MORTIMER IANPRESIDENT & CEO · Director | Exercise / conversionCommon SharesNon-derivative security · Code M | 40,000 | 7.49Value: 299,600Currency not specified | View ↗ |
| Trade: | Kelly Thomas PatrickChief Financial Officer | Stock awardRestricted Share UnitsDerivative security · Code A | 30,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Kelly Thomas PatrickChief Financial Officer | Stock awardShare Option (Right to Buy)Derivative security · Code A | 225,000 | 0Value: 0Currency not specified | View ↗ |
6 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →